|
1
|
Sartor RB: Therapeutic manipulation of the
enteric microflora in inflammatory bowel diseases: antibiotics,
probiotics, and prebiotics. Gastroenterology. 126:1620–1633. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lei X, Liu M, Yang Z, et al: Thymoquinone
prevents and ameliorates dextran sulfate sodium-induced colitis in
mice. Dig Dis Sci. 57:2296–2303. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lichtenstein GR and Rutgeerts P:
Importance of mucosal healing in ulcerative colitis. Inflamm Bowel
Dis. 16:338–346. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yao J, Wang JY, Lai MG, et al: Treatment
of mice with dextran sulfate sodium-induced colitis with human
interleukin 10 secreted by transformed Bifidobacterium longum. Mol
Pharm. 8:488–497. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zaveri NT: Green tea and its polyphenolic
catechins: Medicinal uses in cancer and noncancer applications.
Life Sci. 78:2073–2080. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Higdon JV and Frei B: Tea catechins and
polyphenols: Health effects, metabolism, and antioxidant functions.
Crit Rev Food Sci Nutr. 43:89–143. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang CS, Maliakal P and Meng X: Inhibition
of carcinogenesis by tea. Annu Rev Pharmacol Toxicol. 42:25–54.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Caderni G, De Filippo C, Luceri C,
Salvadori M, Giannini A, Biggeri A, Remy S, Cheynier V and Dolara
P: Effects of black tea, green tea and wine extracts on intestinal
carcinogenesis induced by azoxymethane in F344 rats.
Carcinogenesis. 21:1965–1969. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brückner M, Westphal S, Domschke W,
Kucharzik T and Lügering A: Green tea polyphenol
epigallocatechin-3-gallate shows therapeutic antioxidative effects
in a murine model of colitis. J Crohns Colitis. 6:226–235. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Navarro-Perán E, Cabezas-Herrera J,
Sánchez-Del-Campo L, García-Cánovas F and Rodríguez-López JN: The
anti-inflammatory and anti-cancer properties of
epigallocatechin-3-gallate are mediated by folate cycle disruption,
adenosine release and NF-kappaB suppression. Inflamm Res.
57:472–478. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miura Y, Chiba T, Tomita I, et al: Tea
catechins prevent the development of atherosclerosis in apoprotein
E-deficient mice. J Nutr. 131:27–32. 2001.PubMed/NCBI
|
|
12
|
Ran ZH, Chen C and Xiao SD:
Epigallocatechin-3-gallate ameliorates rats colitis induced by
acetic acid. Biomed Pharmacother. 62:189–196. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eastaff-Leung N, Mabarrack N, Barbour A,
Cummins A and Barry S: Foxp3+ regulatory T Cells, Th17 effector
cells, and cytokine environment in inflammatory bowel disease. J
Clin Immunol. 30:80–89. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cooper HS, Murthy SN, Shah RS and
Sedergran DJ: Clinicopathologic study of dextran sulfate sodium
experimental murine colitis. Lab Invest. 69:238–249.
1993.PubMed/NCBI
|
|
15
|
Shen W and Durum SK: Synergy of IL-23 and
Th17 cytokines: New light on inflammatory bowel disease. Neurochem
Res. 35:940–946. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hardenberg G, Steiner TS and Levings MK:
Environmental influences on T regulatory cells in inflammatory
bowel disease. Semin Immunol. 23:130–138. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fuss IJ, Heller F, Boirivant M, Leon F,
Yoshida M, Fichtner-Feigl S, Yang Z, Exley M, Kitani A, Blumberg
RS, et al: Nonclassical CD1d-restricted NK T cells that produce
IL-13 characterize an atypical Th2 response in ulcerative colitis.
J Clin Invest. 113:1490–1497. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Heller F, Florian P, Bojarski C, Richter
J, Christ M, Hillenbrand B, Mankertz J, Gitter AH, Bürgel N, Fromm
M, et al: Interleukin-13 is the key effector Th2 cytokine in
ulcerative colitis that affects epithelial tight junctions,
apoptosis, and cell restitution. Gastroenterology. 129:550–564.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hunter MM, Wang A and McKay DM: Helminth
infection enhances disease in a murine TH2 model of colitis.
Gastroenterology. 132:1320–1330. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fuss IJ and Strober W: The role of IL-13
and NK T cells in experimental and human ulcerative colitis.
Mucosal Immunol. 1(Suppl 1): S31–S33. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matsumura K, Nakase H, Yamamoto S, Yoshino
T, Takeda Y, Kasahara K, Ueno S, Uza N and Chiba T: Modulation of
the Th1/Th2 balance by infliximab improves hyperthyroidism
associated with a flare-up of ulcerative colitis. Inflamm Bowel
Dis. 15:967–968. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dohi T, Fujihashi K, Kiyono H, Elson CO
and McGhee JR: Mice deficient in Th1- and Th2-type cytokines
develop distinct forms of hapten-induced colitis. Gastroenterology.
119:724–733. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sawa Y, Oshitani N, Adachi K, Higuchi K,
Matsumoto T and Arakawa T: Comprehensive analysis of intestinal
cytokine messenger RNA profile by real-time quantitative polymerase
chain reaction in patients with inflammatory bowel disease. Int J
Mol Med. 11:175–179. 2003.PubMed/NCBI
|
|
24
|
Olsen T, Goll R, Cui G, Husebekk A, Vonen
B, Birketvedt GS and Florholmen J: Tissue levels of tumor necrosis
factor-alpha correlates with grade of inflammation in untreated
ulcerative colitis. Scand J Gastroenterol. 42:1312–1320. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Alex P, Zachos NC, Nguyen T, Gonzales L,
Chen TE, Conklin LS, Centola M and Li X: Distinct cytokine patterns
identified from multiplex profiles of murine DSS and TNBS-induced
colitis. Inflamm Bowel Dis. 15:341–352. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fuss IJ: Is the Th1/Th2 paradigm of immune
regulation applicable to IBD? Inflamm Bowel Dis. 14:S110–S112.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bogaert S, Laukens D, Peeters H, et al:
Differential mucosal expression of Th17-related genes between the
inflamed colon and ileum of patients with inflammatory bowel
disease. BMC Immunol. 11:612010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu ZJ, Yadav PK, Su JL, Wang JS and Fei
K: Potential role of Th17 cells in the pathogenesis of inflammatory
bowel disease. World J Gastroenterol. 15:5784–5788. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Heo YJ, Joo YB, Oh HJ, et al: IL-10
suppresses Th17 cells and promotes regulatory T cells in the CD4+ T
cell population of rheumatoid arthritis patients. Immunol Lett.
127:150–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kleczynska W, Jakiela B, Plutecka H, et
al: Imbalance between Th17 and regulatory T-cells in systemic lupus
erythematosus. Folia Histochem Cytobiol. 49:646–653. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Horiuchi A, Hayashi T, Kikuchi N, et al:
Hypoxia upregulates ovarian cancer invasiveness via the binding of
HIF-1α to a hypoxia-induced, methylation-free hypoxia response
element of S100A4 gene. Int J Cancer. 131:1755–1767. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chu W, Wan L, Zhao D, et al: Mild
hypoxia-induced cardiomyocyte hypertrophy via up-regulation of
HIF-1α-mediated TRPC signalling. J Cell Mol Med. 16:2022–2034.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
OGarra A and Vieira P: Regulatory T cells
and mechanisms of immune system control. Nat Med. 10:801–805. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Veltkamp C, Ruhwald R, Giesem T,
Autschbach F, Kaden I, Veltkamp R, Sartor RB and Stremmel W:
CD4+CD25+ cell depletion from the normal CD4+ T cell pool prevents
tolerance toward the intestinal flora and leads to chronic colitis
in immunodeficient mice. Inflamm Bowel Dis. 12:437–446. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Oconnor W Jr, Kamanaka M, Booth CJ, Town
T, Nakae S, Iwakura Y, Kolls JK and Flavell RA: A protective
function for interleukin 17A in T cell-mediated intestinal
inflammation. Nat Immunol. 10:603–609. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fiocchi C: Inflammatory bowel disease:
evolutionary concepts in biology, epidemiology, mechanisms and
therapy. Curr Opin Gastroenterol. 29:347–349. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gupta S: Immune homeostasis: regulatory T
cells (Treg) and molecules. J Clin Immunol. 28:617–618. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Unutmaz D and Pulendran B: The gut feeling
of Treg cells: IL-10 is the silver lining during colitis. Nat
Immunol. 10:1141–1143. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bettelli E, Carrier Y, Cao W, et al:
Reciprocal developmental pathways for the generation of pathogenic
effector TH17 and regulatory T cells. Nature. 441:235–238. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lina C, Conghua W, Nan L and Ping Z:
Combined treatment of etanercept and MTX reverses Th1/Th2,
Th17/Treg imbalance in patients with rheumatoid arthritis. J Clin
Immunol. 31:596–605. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ben Aissa-Fennira F, Sassi A, Bouguerra A
and Benammar-Elgaaied A: Immunoregulatory role for a public IgM
idiotype in the induction of autoimmune diseases in Mycoplasma
pneumoniae infection. Immunol Lett. 136:130–137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhou L, Lopes JE, Chong MM, et al:
TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by
antagonizing RORgammat function. Nature. 453:236–240. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li MO and Flavell RA: TGF-beta: A master
of all T cell trades. Cell. 134:392–404. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ghoreschi K, Laurence A, Yang XP, et al:
Generation of pathogenic T(H)17 cells in the absence of TGF-β
signalling. Nature. 467:967–971. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang J, Pae M, Meydani SN and Wu D: Green
tea epigallocatechin-3-gallate modulates differentiation of naïve
CD4+ T cells into specific lineage effector cells. J Mol Med
(Berl). 91:485–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Nutsch K and Hsieh C: When T cells run out
of breath: the HIF-1α story. Cell. 146:673–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jung JE, Kim HS, Lee CS, et al: STAT 3
inhibits the degradation of HIF-1alpha by pVHL-mediated
ubiquitination. Exp Mol Med. 40:479–485. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sun H, Zhang Y, Gao P, et al: Adiponectin
reduces C-reactive protein expression and downregulates STAT3
phosphorylation induced by IL-6 in HepG2 cells. Mol Cell Biochem.
347:183–189. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li Y, Yu C, Zhu WM, et al: Triptolide
ameliorates IL-10-deficient mice colitis by mechanisms involving
suppression of IL-6/STAT3 signaling pathway and down-regulation of
IL-17. Mol Immunol. 47:2467–2474. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Veldhoen M, Hocking RJ, Atkins CJ,
Locksley RM and Stockinger B: TGFbeta in the context of an
inflammatory cytokine milieu supports de novo differentiation of
IL-17-producing T cells. Immunity. 24:179–189. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Mangan PR, Harrington LE, OQuinn DB, Helms
WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR and Weaver
CT: Transforming growth factor-beta induces development of the
T(H)17 lineage. Nature. 441:231–234. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Volpe E, Servant N, Zollinger R, Bogiatzi
SI, Hupé P, Barillot E and Soumelis V: A critical function for
transforming growth factor-beta, interleukin 23 and proinflammatory
cytokines in driving and modulating human T(H)-17 responses. Nat
Immunol. 9:650–657. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Harrington LE, Hatton RD, Mangan PR,
Turner H, Murphy TL, Murphy KM and Weaver CT: Interleukin
17-producing CD4+ effector T cells develop via a lineage distinct
from the T helper type 1 and 2 lineages. Nat Immunol. 6:1123–1132.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
54
|
Annunziato F, Cosmi L, Santarlasci V,
Maggi L, Liotta F, Mazzinghi B, Parente E, Filì L, Ferri S, Frosali
F, et al: Phenotypic and functional features of human Th17 cells. J
Exp Med. 204:1849–1861. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lubberts E: Th17 cytokines and arthritis.
Semin Immunopathol. 32:43–53. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Komiyama Y, Nakae S, Matsuki T, Nambu A,
Ishigame H, Kakuta S, Sudo K and Iwakura Y: IL-17 plays an
important role in the development of experimental autoimmune
encephalomyelitis. J Immunol. 177:566–573. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Yang XO, Panopoulos AD, Nurieva R, Chang
SH, Wang D, Watowich SS and Dong C: STAT3 regulates
cytokine-mediated generation of inflammatory helper T cells. J Biol
Chem. 282:9358–9363. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Dryden GW, Fernandez-Botran GR and Qazzaz
HMH: EGCG reduces proinflammatory cytokine production and induces
apoptosis in activated CD14+ macrophages, CD4+CD45+RO T cells, and
mixed macrophage/T cell populations, but not CD4+CD45+RA T cells
from IBD patients and controls. Gastroenterology. 140:S–838.
2011.
|
|
59
|
Dryden GW, Lam A, Beatty K, Qazzaz HH and
McClain CJ: A pilot study to evaluate the safety and efficacy of an
oral dose of (−)-epigallocatechin-3-gallate-rich polyphenon E in
patients with mild to moderate ulcerative colitis. Inflamm Bowel
Dis. 19:1904–1912. 2013.PubMed/NCBI
|
